ArticlebioRxiv : the preprint server for biology2025
Patient-Specific Midbrain Organoids with CRISPR Correction Reveal Disease Mechanisms and Enable Therapeutic Evaluation in Neuronopathic Gaucher Disease.
Yi Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.